We recently published 13 Stocks Jim Cramer Discussed During His Historic Morning Appearance. Chipotle Mexican Grill, Inc. (NYSE:CMG) is one of the stocks Jim Cramer recently discussed. Chipotle Mexican Grill, Inc. (NYSE:CMG)’s shares have lost 35% year-to-date as the firm has struggled with slowing consumer spending. Cramer’s previous comments about the company have pointed out that high prices are the reason that are driving the poor performance. This time, he discussed what Chipotle Mexican Grill, Inc. ...

We recently published 13 Stocks Jim Cramer Discussed During His Historic Morning Appearance. CAVA Group, Inc. (NYSE:CAVA) is one of the stocks Jim Cramer recently discussed. CAVA Group, Inc. (NYSE:CAVA) is another restaurant chain whose shares have struggled in 2025. Cramer believes that high prices are to blame for the woes. In his previous comments about the firm, he has discussed that CAVA Group, Inc. (NYSE:CAVA)’s menu prices and compared them to Brinker’s Chili’s and Maggiano’s. The poor sales have f ...

投资业绩 - 第二季度总回报率为11.79%（毛）和11.56%（净）[1] - 同期罗素中型股增长指数回报率达18.20%[1] - 全球风险因子中Beta、动量和残差波动率获得高回报[1] 市场环境 - 股票实现两位数回报且全球经济活动扩张[1] - 增长指数表现优于价值指数[1] - 中小盘成长股中高估值、负盈利或低股本回报率的股票回报更佳[1] EMCOR集团财务表现 - 第二季度合并收入达43亿美元 同比增长6.375亿美元（17.4%）[4] - 股价单月回报率4.04% 52周累计涨幅63.30%[2] - 期末股价报634.40美元 市值达283.98亿美元[2] EMCOR集团业务亮点 - 提供机电系统建造和运营服务 客户涵盖商业、工业及公共机构领域[3] - 当季贡献45%投资回报率[3] - 收入和盈利超预期 未完成订单量创历史新高且新项目储备健康[3] 机构持仓 - 51家对冲基金持有该股票 较上季度49家有所增加[4] - 未入选对冲基金最受欢迎的30只股票榜单[4]

TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. During the quarter, the fund returned 11.28% (gross) and 11.02% (net), compared to the Russell 2000 Growth Index by 11.97%. Equities posted double-digit returns in the second quarter as global economic activity measures lifted. In addition, please check the fund’s top five holdings to know its best picks in 20 ...

TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. During the quarter, the fund returned 11.28% (gross) and 11.02% (net), compared to the Russell 2000 Growth Index by 11.97%. Equities posted double-digit returns in the second quarter as global economic activity measures lifted. In addition, please check the fund’s top five holdings to know its best picks in 20 ...

基金业绩表现 - TimesSquare Capital Management美国小盘成长策略基金2025年第二季度总回报率为11.28%（毛）和11.02%（净）[1] - 同期Russell 2000成长指数回报率为11.97% 基金表现略低于基准指数0.69个百分点[1] - 全球经济活动指标改善推动股票在第二季度实现两位数回报[1] Ollie's Bargain Outlet基本面 - 公司是美国清仓商品和过剩库存零售商 2025年9月10日股价报收129.73美元 市值达79.54亿美元[2] - 单月股价回报率为-1.65% 但过去52周累计涨幅达32.16%[2] - 季度业绩超预期 同店销售表现优异 收购多家原Big Lots门店并提前完成开业计划[3] 市场关注度 - 32只对冲基金在2025年第二季度持有该公司股票 较前一季度的25只增加7只[4] - 知名财经评论员Jim Cramer公开表示支持该公司 自称"Ollie's Army骄傲成员"[4] - 该公司未入选对冲基金最受欢迎的30只股票名单[4]

基金业绩表现 - Sound Shore Management旗下基金SSHFX和SSHVX在2025年第二季度回报率分别为3.06%和3.10% 低于同期罗素1000价值指数3.79%和标普500指数10.94%的回报率 [1] - 截至2025年6月30日 该基金35年年化回报率SSHFX为14.92% SSHVX为15.14% 高于罗素1000价值指数12.76%但低于标普500指数19.71% [1] 迪士尼公司财务表现 - 迪士尼股价在2025年9月10日收盘报115.79美元 市值达2081.82亿美元 [2] - 该公司近一个月股价下跌0.45% 但过去52周累计上涨29.66% [2] - 第二季度末共有111只对冲基金持有迪士尼股票 较前一季度的104只有所增加 [4] 媒体行业转型 - 传统媒体行业正加速向数字流媒体模式转型 行业参与者正在调整战略投资以应对竞争 [3] - 迪士尼凭借其规模优势和业务重新定位 在美国及海外市场具备增长潜力 [3] - 市场对迪士尼计划在2025年底推出ESPN旗舰流媒体服务表示认可 推动股价创下新高 [3]

Corcept Therapeutics Inc. (NASDAQ:CORT) is one of the best multibagger stocks to invest in right now. The company has recently revised its 2025 revenue guidance to $850-$900 million, down from the previous range of $900-$950 million. Despite the adjustment, management reiterated confidence in the company’s growth trajectory, pointing to contributions from an expanded sales force, new pharmacy partnerships, and progress in its pipeline. Corcept's (CORT) Multibagger Momentum Builds on Relacorilant and Expan ...

Gossamer Bio Inc. (NASDAQ:GOSS) is one of the best multibagger stocks to invest in right now. The company’s focus lies on its lead asset, Seralutinib, which targets pulmonary arterial hypertension (PAH), a severe condition with limited treatment options. Investor enthusiasm for the stock has grown markedly this year. It was trading around $1 at the start of the year and has since climbed to $2.50, delivering nearly 180% returns year-to-date. Piper Sandler Reiterates Buy as Seralutinib Momentum Boosts Goss ...

公司股价表现 - 卡夫亨氏公司股价年初至今下跌13% [2] - 公司宣布将分拆为两家公司并逆转2015年合并后 股价在8月底因此消息下跌7% [2] 公司战略调整 - 公司宣布计划分拆为两家公司 旨在重振增长 [2][3] 品牌与市场挑战 - 公司品牌被指为“老品牌” 面临对年轻消费者吸引力可能下降的挑战 [2] - 具体提及的品牌包括Oscar Mayer、Kraft、Jello和Lunchables [3] - 有观点认为这些品牌在超市中大多位于中间货架区域 缺乏突出表现 [3] - 公司品牌面临消费者包装商品领域的普遍挑战 [3]